Decrease in lung nitric oxide production after peritonitis in mice with sickle cell disease

Critical Care Medicine

Volumn 35, Issue 2, 2007, Pages 502-509

  Bartolucci, Pablo ^a   Ngo, Minh Triet ^a   Beuzard, Yves ^b   Galactéros, Frédéric ^c   Saber, Guitanouch ^a   Rideau, Dominique ^a   Eddahibi, Saadia ^a   Maitre, Bernard ^a   Adnot, Serge ^a,c   Delclaux, Christophe ^a,c,d  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Arginase; Nitric oxide; Nitric oxide synthase; Peritonitis; Sickle cell disease

Indexed keywords

ARGINASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; CECUM; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; MALE; MORTALITY; MOUSE; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS; SICKLE CELL ANEMIA; TRANSGENIC MOUSE;

ANEMIA, SICKLE CELL; ANIMALS; LUNG; MICE; MICE, TRANSGENIC; NITRIC OXIDE; PERITONITIS;

EID: 33846448507     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000253403.65602.EA     Document Type: Article

References (43)

1. Gladwin MT, Schechter AN, Shelhamer JH, et al: The acute chest syndrome in sickle cell disease. Possible role of nitric oxide in its pathophysiology and treatment. Am J Respir Crit Care Med 1999; 159:1368-1376
2. Stuart MJ, Setty BN: Sickle cell acute chest syndrome: Pathogenesis and rationale for treatment. Blood 1999; 94:1555-1560
3. Belhassen L, Pelle G, Sediame S, et al: Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stress-mediated vasodilation. Blood 2001; 97:1584-1589
4. Gladwin MT, Schechter AN, Ognibene FP, et al: Divergent nitric oxide bioavailability in men and women with sickle cell disease. Circulation 2003; 107:271-278
5. Morris CR, Kuypers FA, Larkin S, et al: Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome. J Pediatr Hematol Oncol 2000; 22:515-520
6. Reiter CD, Wang X, Tanus-Santos JE, et al: Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 2002; 8:1383-1389
7. Aslan M, Ryan TM, Adler B, et al: Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. Proc Natl Acad Sci U S A 2001; 98:15215-15220
8. Bank N, Kiroycheva M, Singhal PC, et al: Inhibition of nitric oxide synthase ameliorates cellular injury in sickle cell mouse kidneys. Kidney Int 2000; 58:82-89
9. de Franceschi L, Baron A, Scarpa A, et al: Inhaled nitric oxide protects transgenic SAD mice from sickle cell disease-specific lung injury induced by hypoxia/reoxygenation. Blood 2003; 102:1087-1096
10. Kaul DK, Liu XD, Fabry ME, et al: Impaired nitric oxide-mediated vasodilation in transgenic sickle mouse. Am J Physiol Heart Circ Physiol 2000; 278:H1799-H1806
11. Martinez-Ruiz R, Montero-Huerta P, Hromi J, et al: Inhaled nitric oxide improves survival rates during hypoxia in a sickle cell (SAD) mouse model. Anesthesiology 2001; 94: 1113-1118
12. Nath KA, Shah V, Haggard JJ, et al: Mechanisms of vascular instability in a transgenic mouse model of sickle cell disease. Am J Physiol Regul Integr Comp Physiol 2000; 279: R1949-R1955
13. Vichinsky EP, Neumayr LD, Earles AN, et al: Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med 2000; 342:1855-1865
14. Holtzclaw JD, Jack D, Aguayo SM, et al: Enhanced pulmonary and systemic response to endotoxin in transgenic sickle mice. Am J Respir Crit Care Med 2004; 169:687-695
15. Attalah HL, Honore S, Eddahibi S, et al: Decreased exhaled nitric oxide as a marker of postinsult immune paralysis. J Appl Physiol 2004; 97:1188-1194
16. Bogdan C: Nitric oxide and the immune response. Nat Immunol 2001; 2:907-916
17. Morris CR, Kato GJ, Poljakovic M, et al: Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA 2005; 294:81-90
18. Attalah HL, Azoulay E, Yang K, et al: Granulocyte colony-stimulating factor enhances host defenses against bacterial pneumonia following peritonitis in nonneutropenic rats. Crit Care Med 2002; 30:2107-2114
19. Weicker S, Karachi TA, Scott JA, et al: Noninvasive measurement of exhaled nitric oxide in a spontaneously breathing mouse. Am J Respir Crit Care Med 2001; 163:1113-1116
20. Yang F, Troncy E, Francoeur M, et al: Effects of reducing reagents and temperature on conversion of nitrite and nitrate to nitric oxide and detection of NO by chemiluminescence. Clin Chem 1997; 43:657-662
21. Giraldez RR, Zweier JL: An improved assay for measurement of nitric oxide synthase activity in biological tissues. Anal Biochem 1998; 261:29-35
22. Jean D, Maitre B, Tankovic J, et al: Beneficial effects of nitric oxide inhalation on pulmonary bacterial clearance. Crit Care Med 2002; 30:442-447
23. Stocker JW, De Franceschi L, McNaughton-Smith GA, et al: ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD mice. Blood 2003; 101:2412-2418
24. De Franceschi L, Brugnara C, Rouyer-Fessard P, et al: Formation of dense erythrocytes in SAD mice exposed to chronic hypoxia: Evaluation of different therapeutic regimens and of a combination of oral clotrimazole and magnesium therapies. Blood 1999; 94:4307-4313
25. Blouin MJ, De Paepe ME, Trudel M: Altered hematopoiesis in murine sickle cell disease. Blood 1999; 94:1451-1459
26. Trudel M, De Paepe ME, Chretien N, et al: Sickle cell disease of transgenic SAD mice. Blood 1994; 84:3189-3197
27. Hammerman SI, Klings ES, Hendra KP, et al: Endothelial cell nitric oxide production in acute chest syndrome. Am J Physiol 1999; 277:H1579-H1592
28. Weisz A, Oguchi S, Cicatiello L, et al: Dual mechanism for the control of inducible-type NO synthase gene expression in macrophages during activation by interferon-gamma and bacterial lipopolysaccharide. Transcriptional and post-transcriptional regulation. J Biol Chem 1994; 269:8324-8333
29. Perez-Sala D, Cernuda-Morollon E, Diaz-Cazorla M, et al: Posttranscriptional regulation of human iNOS by the NO/cGMP pathway. Am J Physiol Renal Physiol 2001; 280: F466-F473
30. Delclaux C, Zerah-Lancner F, Bachir D, et al: Factors associated with dyspnea in adult patients with sickle cell disease. Chest 2005; 128:3336-3344
31. Connelly L, Madhani M, Hobbs AJ: Resistance to endotoxic shock in endothelial nitric-oxide synthase (eNOS) knock-out mice: A pro-inflammatory role for eNOS-derived no in vivo. J Biol Chem 2005; 280:10040-10046
32. Vo PA, Lad B, Tomlinson JA, et al: autoregulatory role of endothelium-derived nitric oxide (NO) on lipopolysaccharide-induced vascular inducible NO synthase expression and function. J Biol Chem 2005; 280: 7236-7243
33. Ermert M, Ruppert C, Gunther A, et al: Cell-specific nitric oxide synthase-isoenzyme expression and regulation in response to endotoxin in intact rat lungs. Lab Invest 2002; 82:425-441
34. Que LG, Kantrow SP, Jenkinson CP, et al: Induction of arginase isoforms in the lung during hyperoxia. Am J Physiol 1998; 275: L96-L102
35. Zhang C, Hein TW, Wang W, et al: Constitutive expression of arginase in microvascular endothelial cells counteracts nitric oxide-mediated vasodilatory function. FASEB J 2001; 15:1264-1266
36. Salimuddin, Nagasaki A, Gotoh T, et al: Regulation of the genes for arginase isoforms and related enzymes in mouse macrophages by lipopolysaccharide. Am J Physiol 1999; 277:E110-E117
37. Sullivan KJ, Goodwin SR, Evangelist J, et al: Nitric oxide successfully used to treat acute chest syndrome of sickle cell disease in a young adolescent. Crit Care Med 1999; 27: 2563-2568
38. De Franceschi L, Malpeli G, Scarpa A, et al: Protective effects of S-nitroso-albumin on lung injury induced by hypoxia/reoxygenation in a mouse model of sickle cell disease. Am J Physiol Lung Cell Mol Physiol 2006; 291:L457-465
39. Weiner DL, Hibberd PL, Betit P, et al: Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease. JAMA 2003; 289:1136-1142
40. Gladwin MT, Schechter AN, Shelhamer JH, et al: Inhaled nitric oxide augments nitric oxide transport on sickle cell hemoglobin without affecting oxygen affinity. J Clin Invest 1999; 104:937-945
41. Cauwels A, Van Molle W, Janssen B, et al: Protection against TNF-induced lethal shock by soluble guanylate cyclase inhibition requires functional inducible nitric oxide synthase. Immunity 2000; 13:223-231
42. Volman TJ, Goris RJ, van der Jagt M, et al: Organ damage in zymosan-induced multiple organ dysfunction syndrome in mice is not mediated by inducible nitric oxide synthase. Crit Care Med 2002; 30:1553-1559
43. Kalil AC, Sevransky JE, Myers DE, et al: Preclinical trial of l-arginine monotherapy alone or with N-acetylcysteine in septic shock. Crit Care Med 2006; 34:2719-2728